225 related articles for article (PubMed ID: 35884436)
1. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
Puiggros A; Ramos-Campoy S; Kamaso J; de la Rosa M; Salido M; Melero C; Rodríguez-Rivera M; Bougeon S; Collado R; Gimeno E; García-Serra R; Alonso S; Moro-García MA; García-Malo MD; Calvo X; Arenillas L; Ferrer A; Mantere T; Hoischen A; Schoumans J; Espinet B
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884436
[TBL] [Abstract][Full Text] [Related]
2.
Ramos-Campoy S; Puiggros A; Kamaso J; Beà S; Bougeon S; Larráyoz MJ; Costa D; Parker H; Rigolin GM; Blanco ML; Collado R; Ancín I; Salgado R; Moro-García MA; Baumann T; Gimeno E; Moreno C; Salido M; Calvo X; Calasanz MJ; Cuneo A; Nguyen-Khac F; Oscier D; Haferlach C; Strefford JC; Schoumans J; Espinet B
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954380
[TBL] [Abstract][Full Text] [Related]
3. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
[TBL] [Abstract][Full Text] [Related]
4. Comparative Benchmarking of Optical Genome Mapping and Chromosomal Microarray Reveals High Technological Concordance in CNV Identification and Additional Structural Variant Refinement.
Barseghyan H; Pang AWC; Clifford B; Serrano MA; Chaubey A; Hastie AR
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895217
[TBL] [Abstract][Full Text] [Related]
5. Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients.
Ramos-Campoy S; Puiggros A; Beà S; Bougeon S; Larráyoz MJ; Costa D; Parker H; Rigolin GM; Ortega M; Blanco ML; Collado R; Salgado R; Baumann T; Gimeno E; Moreno C; Bosch F; Calvo X; Calasanz MJ; Cuneo A; Strefford JC; Nguyen-Khac F; Oscier D; Haferlach C; Schoumans J; Espinet B
Haematologica; 2022 Mar; 107(3):593-603. PubMed ID: 33691382
[TBL] [Abstract][Full Text] [Related]
6. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
[TBL] [Abstract][Full Text] [Related]
8. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
[TBL] [Abstract][Full Text] [Related]
9. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
[TBL] [Abstract][Full Text] [Related]
10. Optical Genome Mapping for Comprehensive Assessment of Chromosomal Aberrations and Discovery of New Fusion Genes in Pediatric B-Acute Lymphoblastic Leukemia.
Gao H; Xu H; Wang C; Cui L; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Zhang R; Li Z; Wang T
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612032
[TBL] [Abstract][Full Text] [Related]
11. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
12. Optical genome mapping enables constitutional chromosomal aberration detection.
Mantere T; Neveling K; Pebrel-Richard C; Benoist M; van der Zande G; Kater-Baats E; Baatout I; van Beek R; Yammine T; Oorsprong M; Hsoumi F; Olde-Weghuis D; Majdali W; Vermeulen S; Pauper M; Lebbar A; Stevens-Kroef M; Sanlaville D; Dupont JM; Smeets D; Hoischen A; Schluth-Bolard C; El Khattabi L
Am J Hum Genet; 2021 Aug; 108(8):1409-1422. PubMed ID: 34237280
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
Díaz-González Á; Mora E; Avetisyan G; Furió S; De la Puerta R; Gil JV; Liquori A; Villamón E; García-Hernández C; Santiago M; García-Ruiz C; Llop M; Ferrer-Lores B; Barragán E; García-Palomares S; Mayordomo E; Luna I; Vicente A; Cordón L; Senent L; Álvarez-Larrán A; Cervera J; De la Rubia J; Hernández-Boluda JC; Such E
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297002
[TBL] [Abstract][Full Text] [Related]
15. Optical Genome Mapping: A Revolutionary Tool for "Next Generation Cytogenomics Analysis" with a Broad Range of Diagnostic Applications in Human Diseases.
Garcia-Heras J
J Assoc Genet Technol; 2021; 47(4):191-200. PubMed ID: 34897113
[TBL] [Abstract][Full Text] [Related]
16. Detection of complex chromosome rearrangements using optical genome mapping.
Qu J; Li S; Yu D
Gene; 2023 Oct; 884():147688. PubMed ID: 37543218
[TBL] [Abstract][Full Text] [Related]
17. Optical genome mapping for prenatal diagnosis: A prospective study.
Goumy C; Guy Ouedraogo Z; Soler G; Eymard-Pierre E; Laurichesse H; Delabaere A; Gallot D; Bouchet P; Perthus I; Pebrel-Richard C; Gouas L; Salaun G; Salse J; Véronèse L; Tchirkov A
Clin Chim Acta; 2023 Nov; 551():117594. PubMed ID: 37832906
[TBL] [Abstract][Full Text] [Related]
18. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
[TBL] [Abstract][Full Text] [Related]
19. High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance.
Yang H; Garcia-Manero G; Sasaki K; Montalban-Bravo G; Tang Z; Wei Y; Kadia T; Chien K; Rush D; Nguyen H; Kalia A; Nimmakayalu M; Bueso-Ramos C; Kantarjian H; Medeiros LJ; Luthra R; Kanagal-Shamanna R
Leukemia; 2022 Sep; 36(9):2306-2316. PubMed ID: 35915143
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]